The Financial Times is reporting that Novartis is working with Proteus Biomedical on implanting tiny chips into blood pressure tablets. Proteus has created tiny swallowable microchips that can communicate with a shoulder worn sensor and a small clinical trial is testing whether this can be used to track and improve drug regiment compliance. An executive with Novartis tells FT that so far compliance in the trial has increased from 30 to 80 percent.
Link to Financial Times: Novartis chip to help ensure bitter pills are swallowed…
Flashbacks: NextGen Pharmaceuticals: Pills That Talk, Sensors That Listen; Chip-on-a-Pill, and Other Micro-Electro-Medical Devices
(hat tip: WSJ Health Blog)